Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Cassava Sciences Inc (SAVA)

Cassava Sciences Inc (SAVA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
United Therapeutics (UTHR) Q4 Earnings Miss, Sales Beat

United Therapeutics' (UTHR) fourth-quarter earnings miss estimates while sales beat the same. Higher sales of Orenitram, Remodulin and Tyvaso offset lower sales of Unituxin and Adcirca.

MDT : 118.32 (-0.35%)
LLY : 203.75 (-0.38%)
UTHR : 170.58 (-1.80%)
SAVA : 51.44 (-3.05%)
Jazz Pharma (JAZZ) Q4 Earnings Miss, 2021 Sales View Dull

Jazz Pharmaceuticals (JAZZ) reports mixed fourth-quarter 2020 results as earnings miss estimates while sales beat the same. Shares down.

JAZZ : 171.98 (-0.88%)
USNA : 96.04 (+2.41%)
GWPH : 215.20 (+0.09%)
SAVA : 51.44 (-3.05%)
Cassava Sciences, Inc. (SAVA) Stock Sinks As Market Gains: What You Should Know

Cassava Sciences, Inc. (SAVA) closed the most recent trading day at $52.37, moving -1.23% from the previous trading session.

SAVA : 51.44 (-3.05%)
Cassava Sciences (SAVA) to Post Q4 Earnings: What's in Store?

Cassava Sciences (SAVA) will provide updates on its pipelinewhen it reports fourth-quarter 2020 results.

MRNA : 151.91 (+4.92%)
AVIR : 81.82 (+2.27%)
SAVA : 51.44 (-3.05%)
CSTL : 76.40 (-8.18%)
Cassava Sciences to Present at SVB Leerink Global Healthcare Conference

Cassava Sciences, Inc. (Nasdaq: SAVA), a clinical-stage biotechnology company developing product candidates for Alzheimer's disease, has been invited to present at the 10th Annual SVB Leerink Global Healthcare...

SAVA : 51.44 (-3.05%)
Cassava Sciences Announces Positive End-of-Phase 2 Meeting with FDA and Outlines Pivotal Phase 3 Program for Simufilam in Alzheimer's Disease

- Two Upcoming Phase 3 Studies and a Previously Completed Phase 2 Program Support a New Drug Application Filing for Simufilam in Alzheimer's disease -

SAVA : 51.44 (-3.05%)
Thinking about trading options or stock in Kohl's, Cassava Sciences, Caterpillar, United Airlines, or Foot Locker?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for KSS, SAVA, CAT, UAL, and FL.

SAVA : 51.44 (-3.05%)
UAL : 52.45 (-4.57%)
CAT : 223.77 (+0.58%)
FL : 53.60 (-2.10%)
KSS : 55.64 (-0.09%)
Is Cassava Sciences (SAVA) Stock Outpacing Its Medical Peers This Year?

Is (SAVA) Outperforming Other Medical Stocks This Year?

SAVA : 51.44 (-3.05%)
Cassava Sciences, Inc. (SAVA) Dips More Than Broader Markets: What You Should Know

Cassava Sciences, Inc. (SAVA) closed the most recent trading day at $51.22, moving -1.18% from the previous trading session.

SAVA : 51.44 (-3.05%)
Dow Stays in Record Territory to Start Short Week

Dow Stays in Record Territory to Start Short Week

BABA : 244.59 (-2.30%)
VIRT : 28.17 (+4.33%)
SWKS : 180.23 (-5.32%)
MAR : 152.73 (-3.03%)
INTU : 394.50 (-4.52%)
NUAN : 43.45 (-3.04%)
F : 11.97 (-2.44%)
CWH : 33.94 (-8.69%)
TMHC : 27.49 (-6.27%)
EMKR : 6.92 (-1.56%)
PRIM : 34.78 (-2.82%)
TEX : 42.07 (-2.28%)
SQ : 233.34 (-1.68%)
CDAY : 88.30 (-2.07%)
HTHT : 59.24 (+0.65%)
VLO : 79.21 (+1.34%)
XPO : 116.27 (-1.57%)
CCJ : 16.48 (+1.98%)
SLB : 29.10 (-1.05%)
JO : 40.11 (+1.42%)
TAL : 78.98 (-2.90%)
TDC : 41.88 (-4.12%)
VSAT : 53.65 (-2.33%)
NIB : 33.12 (+2.00%)
BMRN : 82.49 (-1.00%)
AA : 26.03 (-4.30%)
VSTO : 33.14 (-0.60%)
KBH : 39.97 (-3.94%)
SAVA : 51.44 (-3.05%)
X : 18.04 (-6.58%)
APHA : 18.92 (-5.73%)
HEXO : 7.27 (-6.44%)
ACB : 11.19 (-3.87%)
Cassava Sciences Announces Closing of $200 Million Registered Direct Offering

Cassava Sciences, Inc. (Nasdaq: SAVA) (the "Company" or "Cassava Sciences"), a clinical-stage biotechnology company focused on Alzheimer's disease, today announced the closing of its previously announced...

SAVA : 51.44 (-3.05%)
Cassava Sciences Announces $200 Million Registered Direct Offering of Common Stock

Cassava Sciences, Inc. (Nasdaq: SAVA) (the "Company" or "Cassava Sciences"), a clinical-stage biotechnology company focused on Alzheimer's disease, today announced that it has entered into a definitive...

SAVA : 51.44 (-3.05%)
Cassava (SAVA) Rises on Late-Stage Alzheimer's Study Plans

Cassava (SAVA) provides outline for future study plans on its Alzheimer's disease candidate, simufilam.

BIIB : 278.60 (-1.46%)
PFE : 33.80 (+0.15%)
BHVN : 84.38 (-1.60%)
SAVA : 51.44 (-3.05%)
Cassava Sciences Announces Significant Program Progress and Expected Key Milestones in 2021 for Its Clinical Program in Alzheimer's Disease

Cassava Sciences, Inc. (Nasdaq: SAVA), a clinical-stage biotechnology company developing product candidates for Alzheimer's disease, today announced significant program progress and expected milestones...

SAVA : 51.44 (-3.05%)
Thinking about buying stock in Cassava Sciences, Qualcomm, Virgin Galactic, General Electric, or eBay?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for SAVA, QCOM, SPCE, GE, and EBAY.

EBAY : 57.66 (-2.90%)
QCOM : 138.03 (-2.18%)
SAVA : 51.44 (-3.05%)
GE : 12.91 (-1.60%)
SPCE : 44.14 (-4.29%)
Biotech Bonanza: COVID Launches Science at Warp Speed

From vaccines to diagnostics, the opportunities in biotechnology are rich for those who do their homework.

HOLX : 72.19 (-3.94%)
MRNA : 151.91 (+4.92%)
VIVO : 22.36 (+1.18%)
NVAX : 234.20 (-2.39%)
AXSM : 70.25 (-2.40%)
AVXL : 13.59 (+9.95%)
VXRT : 7.91 (+7.77%)
SAVA : 51.44 (-3.05%)
Biotech Stock Roundup: AMGN, VRTX Q4 Results, SAVA's Encouraging Drug Data & More

Earnings of leading biotechs like Amgen (AMGN) and Vertex (VRTX) and vaccine updates from Novavax (NVAX) were some of the highlights of the biotech sector last week.

BIIB : 278.60 (-1.46%)
AMGN : 228.11 (-0.82%)
VRTX : 213.24 (-1.75%)
NVAX : 234.20 (-2.39%)
CNCE : 6.96 (+1.61%)
VIE : 52.94 (-0.02%)
SAVA : 51.44 (-3.05%)
Thinking about trading options or stock in Moderna, Cassava Sciences, Tilray, Sony, or ServiceNow?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for MRNA, SAVA, TLRY, SNE, and NOW.

MRNA : 151.91 (+4.92%)
SAVA : 51.44 (-3.05%)
TLRY : 25.49 (-8.90%)
NOW : 535.49 (-2.96%)
SNE : 107.94 (-1.51%)
Cassava (SAVA) Soars on Encouraging Alzheimer's Study Data

Cassava's (SAVA) Alzheimer's disease candidate, simufilam, improved cognition and behavior scores following six months of treatment in an open-label clinical study.

BIIB : 278.60 (-1.46%)
PFE : 33.80 (+0.15%)
BHVN : 84.38 (-1.60%)
SAVA : 51.44 (-3.05%)
Market Jumps Over 1% While Waiting for Amazon, Alphabet

Market Jumps Over 1% While Waiting for Amazon, Alphabet

MRC : 9.35 (-0.53%)
CNDT : 5.72 (+2.51%)
SAVA : 51.44 (-3.05%)
NOW : 535.49 (-2.96%)
SQ : 233.34 (-1.68%)
CCS : 53.37 (-6.20%)
NXGN : 18.81 (-0.11%)
ARMK : 38.54 (-2.68%)
PDD : 178.71 (-0.34%)
LUV : 58.93 (-0.61%)
ILMN : 446.47 (-3.16%)
GME : 144.65 (+57.73%)
AMC : 9.04 (-0.55%)
AAPL : 123.07 (-1.82%)
AMZN : 3,105.29 (-1.72%)
GOOG : 2,053.65 (-1.98%)

Van Meerten Stock Picks

5 Great Small Caps
Summary 100% technical buy signals.
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

Barchart Futures Commentary

Barchart Futures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar